{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:35:07Z","timestamp":1793039707842,"version":"4.5.0"},"reference-count":195,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002858","name":"the Postdoctoral Science Foundation of China","doi-asserted-by":"crossref","award":["2024M752949"],"award-info":[{"award-number":["2024M752949"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"the Postdoctoral Science Foundation of China","doi-asserted-by":"crossref","award":["2024M752949"],"award-info":[{"award-number":["2024M752949"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"the Postdoctoral Science Foundation of China","doi-asserted-by":"crossref","award":["2024M752949"],"award-info":[{"award-number":["2024M752949"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"the Postdoctoral Science Foundation of China","doi-asserted-by":"crossref","award":["2024M752949"],"award-info":[{"award-number":["2024M752949"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12035-024-04672-w","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T07:19:55Z","timestamp":1736234395000},"page":"6283-6307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cholesterol Metabolism in CNS Diseases: The Potential of SREBP2 and LXR as Therapeutic Targets"],"prefix":"10.1007","volume":"62","author":[{"given":"Ning-Qi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Xiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Qi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"4672_CR1","doi-asserted-by":"publisher","unstructured":"Bj\u00f6rkhem I, Meaney S (2004) Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 806\u2013815. https:\/\/doi.org\/10.1161\/01.ATV.0000120374.59826.1b","DOI":"10.1161\/01.ATV.0000120374.59826.1b"},{"key":"4672_CR2","doi-asserted-by":"publisher","unstructured":"Zhang J, Liu Q (2015) Cholesterol metabolism and homeostasis in the brain. Protein Cell 254\u2013264. https:\/\/doi.org\/10.1007\/s13238-014-0131-3","DOI":"10.1007\/s13238-014-0131-3"},{"key":"4672_CR3","doi-asserted-by":"publisher","unstructured":"Genaro-Mattos TC, Anderson A, Allen LB, Korade Z, Mirnics K (2019) Cholesterol biosynthesis and uptake in developing neurons. ACS Chem Neurosci 3671\u20133681. https:\/\/doi.org\/10.1021\/acschemneuro.9b00248","DOI":"10.1021\/acschemneuro.9b00248"},{"key":"4672_CR4","doi-asserted-by":"publisher","unstructured":"Liu Q, Trotter J, Zhang J, Peters MM, Cheng H, Bao J et al (2010) Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration. J Neurosci 17068\u201317078. https:\/\/doi.org\/10.1523\/jneurosci.4067-10.2010","DOI":"10.1523\/jneurosci.4067-10.2010"},{"key":"4672_CR5","doi-asserted-by":"publisher","unstructured":"Hannah MJ, Schmidt AA, Huttner WB (1999) Synaptic vesicle biogenesis. Annu Rev Cell Dev Biol 733\u2013798. https:\/\/doi.org\/10.1146\/annurev.cellbio.15.1.733","DOI":"10.1146\/annurev.cellbio.15.1.733"},{"key":"4672_CR6","doi-asserted-by":"publisher","unstructured":"Yue HY, Xu J (2015) Cholesterol regulates multiple forms of vesicle endocytosis at a mammalian central synapse. J Neurochem 247\u2013260. https:\/\/doi.org\/10.1111\/jnc.13129","DOI":"10.1111\/jnc.13129"},{"key":"4672_CR7","doi-asserted-by":"publisher","unstructured":"Barnes-V\u00e9lez JA, Aksoy Yasar FB, Hu J (2023) Myelin lipid metabolism and its role in myelination and myelin maintenance. Innovation (Camb) 100360.https:\/\/doi.org\/10.1016\/j.xinn.2022.100360","DOI":"10.1016\/j.xinn.2022.100360"},{"key":"4672_CR8","doi-asserted-by":"publisher","unstructured":"Brown MS, Goldstein JL (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 331\u2013340. https:\/\/doi.org\/10.1016\/s0092-8674(00)80213-5","DOI":"10.1016\/s0092-8674(00)80213-5"},{"key":"4672_CR9","doi-asserted-by":"publisher","unstructured":"Wang B, Tontonoz P (2018) Liver X receptors in lipid signalling and membrane homeostasis. Nat Rev Endocrinol 452\u2013463. https:\/\/doi.org\/10.1038\/s41574-018-0037-x","DOI":"10.1038\/s41574-018-0037-x"},{"key":"4672_CR10","doi-asserted-by":"publisher","unstructured":"Vitali C, Wellington CL, Calabresi L (2014) HDL and cholesterol handling in the brain. Cardiovasc Res 405\u2013413. https:\/\/doi.org\/10.1093\/cvr\/cvu148","DOI":"10.1093\/cvr\/cvu148"},{"key":"4672_CR11","doi-asserted-by":"publisher","unstructured":"Saher G, Stumpf SK (2015) Cholesterol in myelin biogenesis and hypomyelinating disorders. Biochim Biophys Acta 1083\u20131094. https:\/\/doi.org\/10.1016\/j.bbalip.2015.02.010","DOI":"10.1016\/j.bbalip.2015.02.010"},{"key":"4672_CR12","doi-asserted-by":"publisher","unstructured":"Nieweg K, Schaller H, Pfrieger FW (2009) Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. J Neurochem 125\u2013134. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.05917.x","DOI":"10.1111\/j.1471-4159.2009.05917.x"},{"key":"4672_CR13","doi-asserted-by":"publisher","unstructured":"Camargo N, Goudriaan A, van Deijk AF, Otte WM, Brouwers JF, Lodder H et al (2017) Oligodendroglial myelination requires astrocyte-derived lipids. PLoS Biol e1002605. https:\/\/doi.org\/10.1371\/journal.pbio.1002605","DOI":"10.1371\/journal.pbio.1002605"},{"key":"4672_CR14","doi-asserted-by":"publisher","unstructured":"Barres BA, Smith SJ (2001) Neurobiology. Cholesterol--making or breaking the synapse. Science 1296\u20131297. https:\/\/doi.org\/10.1126\/science.1066724","DOI":"10.1126\/science.1066724"},{"key":"4672_CR15","doi-asserted-by":"publisher","unstructured":"Rodwell VW, Nordstrom JL, Mitschelen JJ (1976) Regulation of HMG-CoA reductase. Adv Lipid Res 1\u201374.https:\/\/doi.org\/10.1016\/b978-0-12-024914-5.50008-5","DOI":"10.1016\/b978-0-12-024914-5.50008-5"},{"key":"4672_CR16","doi-asserted-by":"publisher","unstructured":"Debose-Boyd RA (2008) Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res 609\u2013621. https:\/\/doi.org\/10.1038\/cr.2008.61","DOI":"10.1038\/cr.2008.61"},{"key":"4672_CR17","doi-asserted-by":"publisher","unstructured":"Xiong H, Callaghan D, Jones A, Walker DG, Lue LF, Beach T G et al (2008) Cholesterol retention in Alzheimer\u2019s brain is responsible for high beta- and gamma-secretase activities and Abeta production. Neurobiol Dis 422\u2013437. https:\/\/doi.org\/10.1016\/j.nbd.2007.10.005","DOI":"10.1016\/j.nbd.2007.10.005"},{"key":"4672_CR18","doi-asserted-by":"publisher","unstructured":"Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K et al (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 2070\u20132075. https:\/\/doi.org\/10.1073\/pnas.0305799101","DOI":"10.1073\/pnas.0305799101"},{"key":"4672_CR19","doi-asserted-by":"publisher","unstructured":"Turri M, Conti E, Pavanello C, Gastoldi F, Palumbo M, Bernini F et al (2023) Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer\u2019s disease. Alzheimers Res Ther 95. https:\/\/doi.org\/10.1186\/s13195-023-01241-6","DOI":"10.1186\/s13195-023-01241-6"},{"key":"4672_CR20","doi-asserted-by":"publisher","unstructured":"Del Toro D, Xifr\u00f3 X, Pol A, Humbert S, Saudou F, Canals JM et al (2010) Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington\u2019s disease. J Neurochem 153\u2013167. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06912.x","DOI":"10.1111\/j.1471-4159.2010.06912.x"},{"key":"4672_CR21","doi-asserted-by":"publisher","unstructured":"Valenza M, Rigamonti D, Goffredo D, Zuccato C, Fenu S, Jamot L et al (2005) Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease. J Neurosci 9932\u20139939. https:\/\/doi.org\/10.1523\/jneurosci.3355-05.2005","DOI":"10.1523\/jneurosci.3355-05.2005"},{"key":"4672_CR22","doi-asserted-by":"publisher","unstructured":"Leoni V, Mariotti C, Tabrizi SJ, Valenza M, Wild EJ, Henley SM et al (2008) Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington\u2019 s disease. Brain 2851\u20132859. https:\/\/doi.org\/10.1093\/brain\/awn212","DOI":"10.1093\/brain\/awn212"},{"key":"4672_CR23","doi-asserted-by":"publisher","unstructured":"Berghoff SA, Spieth L, Sun T, Hosang L, Schlaphoff L, Depp C et al (2021) Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis. Nat Neurosci 47\u201360. https:\/\/doi.org\/10.1038\/s41593-020-00757-6","DOI":"10.1038\/s41593-020-00757-6"},{"key":"4672_CR24","doi-asserted-by":"publisher","unstructured":"Kim WS, Weickert CS, Garner B (2008) Role of ATP-binding cassette transporters in brain lipid transport and neurological disease. J Neurochem 1145\u20131166. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05099.x","DOI":"10.1111\/j.1471-4159.2007.05099.x"},{"key":"4672_CR25","doi-asserted-by":"publisher","unstructured":"Rushworth JV, Griffiths HH, Watt NT, Hooper NM (2013) Prion protein-mediated toxicity of amyloid-\u03b2 oligomers requires lipid rafts and the transmembrane LRP1. J Biol Chem 8935\u20138951. https:\/\/doi.org\/10.1074\/jbc.M112.400358","DOI":"10.1074\/jbc.M112.400358"},{"key":"4672_CR26","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Sanz P, J M F G A, Moratalla R (2021) The role of cholesterol in \u03b1-Synuclein and Lewy body pathology in GBA1 Parkinson\u2019s disease. Mov Disord 1070\u20131085. https:\/\/doi.org\/10.1002\/mds.28396","DOI":"10.1002\/mds.28396"},{"key":"4672_CR27","doi-asserted-by":"publisher","unstructured":"Meaney S, Bodin K, Diczfalusy U, Bj\u00f6rkhem I (2002) On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function. J Lipid Res 2130\u20132135. https:\/\/doi.org\/10.1194\/jlr.m200293-jlr200","DOI":"10.1194\/jlr.m200293-jlr200"},{"key":"4672_CR28","doi-asserted-by":"publisher","unstructured":"Dai L, Zou L, Meng L, Qiang G, Yan M, Zhang Z (2021) Cholesterol metabolism in neurodegenerative diseases: molecular mechanisms and therapeutic targets. Mol Neurobiol 2183\u20132201. https:\/\/doi.org\/10.1007\/s12035-020-02232-6","DOI":"10.1007\/s12035-020-02232-6"},{"key":"4672_CR29","doi-asserted-by":"publisher","unstructured":"Panzenboeck U, Balazs Z, Sovic A, Hrzenjak A, Levak-Frank S, Wintersperger A et al (2002) ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells. J Biol Chem 42781\u201342789. https:\/\/doi.org\/10.1074\/jbc.M207601200","DOI":"10.1074\/jbc.M207601200"},{"key":"4672_CR30","doi-asserted-by":"publisher","unstructured":"Bryleva EY, Rogers MA, Chang CC, Buen F, Harris BT, Rousselet E et al (2010) ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD. Proc Natl Acad Sci U S A 3081\u20133086. https:\/\/doi.org\/10.1073\/pnas.0913828107","DOI":"10.1073\/pnas.0913828107"},{"key":"4672_CR31","doi-asserted-by":"publisher","unstructured":"W\u00fcstner D, Mondal M, Tabas I, Maxfield FR (2005) Direct observation of rapid internalization and intracellular transport of sterol by macrophage foam cells. Traffic 396\u2013412. https:\/\/doi.org\/10.1111\/j.1600-0854.2005.00285.x","DOI":"10.1111\/j.1600-0854.2005.00285.x"},{"key":"4672_CR32","doi-asserted-by":"publisher","unstructured":"Brown MS, Radhakrishnan A, Goldstein JL (2018) Retrospective on cholesterol homeostasis: the central role of scap. Annu Rev Biochem 783\u2013807. https:\/\/doi.org\/10.1146\/annurev-biochem-062917-011852","DOI":"10.1146\/annurev-biochem-062917-011852"},{"key":"4672_CR33","doi-asserted-by":"publisher","unstructured":"Tsai YC, Leichner GS, Pearce MM, Wilson GL, Wojcikiewicz RJ, Roitelman J et al (2012) Differential regulation of HMG-CoA reductase and Insig-1 by enzymes of the ubiquitin-proteasome system. Mol Biol Cell 4484\u20134494. https:\/\/doi.org\/10.1091\/mbc.E12-08-0631","DOI":"10.1091\/mbc.E12-08-0631"},{"key":"4672_CR34","doi-asserted-by":"publisher","unstructured":"Gong X, Qian H, Shao W, LI J, Wu J, Liu JJ et al (2016) Complex structure of the fission yeast SREBP-SCAP binding domains reveals an oligomeric organization. Cell Res 1197\u20131211. https:\/\/doi.org\/10.1038\/cr.2016.123","DOI":"10.1038\/cr.2016.123"},{"key":"4672_CR35","doi-asserted-by":"publisher","unstructured":"Goldstein JL, Debose-Boyd RA, Brown MS (2006) Protein sensors for membrane sterols. Cell 35\u201346. https:\/\/doi.org\/10.1016\/j.cell.2005.12.022","DOI":"10.1016\/j.cell.2005.12.022"},{"key":"4672_CR36","doi-asserted-by":"publisher","unstructured":"Bilotta MT, Petillo S, Santoni A, Cippitelli M (2020) Liver X receptors: regulators of cholesterol metabolism, inflammation, autoimmunity, and cancer. Front Immunol 584303. https:\/\/doi.org\/10.3389\/fimmu.2020.584303","DOI":"10.3389\/fimmu.2020.584303"},{"key":"4672_CR37","doi-asserted-by":"publisher","unstructured":"Zorrilla Veloz RI, Mckenzie T, Palacios BE, Hu J (2022) Nuclear hormone receptors in demyelinating diseases. J Neuroendocrinol e13171. https:\/\/doi.org\/10.1111\/jne.13171","DOI":"10.1111\/jne.13171"},{"key":"4672_CR38","doi-asserted-by":"publisher","unstructured":"Zelcer N, Hong C, Boyadjian R, Tontonoz P (2009) LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 100\u2013104. https:\/\/doi.org\/10.1126\/science.1168974","DOI":"10.1126\/science.1168974"},{"key":"4672_CR39","doi-asserted-by":"publisher","unstructured":"Wong J, Quinn CM, Brown AJ (2006) SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR. Biochem J 485\u2013491. https:\/\/doi.org\/10.1042\/bj20060914","DOI":"10.1042\/bj20060914"},{"key":"4672_CR40","doi-asserted-by":"publisher","unstructured":"Thomas DG, Doran AC, Fotakis P, Westerterp M, Antonson P, Jiang H et al (2018) LXR suppresses inflammatory gene expression and neutrophil migration through cis-repression and cholesterol efflux. Cell Rep 3774-3785. https:\/\/doi.org\/10.1016\/j.celrep.2018.11.100 (e3774)","DOI":"10.1016\/j.celrep.2018.11.100"},{"key":"4672_CR41","doi-asserted-by":"publisher","unstructured":"Goritz C, Mauch DH, Pfrieger FW (2005) Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron. Mol Cell Neurosc 190\u2013201. https:\/\/doi.org\/10.1016\/j.mcn.2005.02.006","DOI":"10.1016\/j.mcn.2005.02.006"},{"key":"4672_CR42","doi-asserted-by":"publisher","unstructured":"Essayan-Perez S, S\u00fcdhof TC (2023) Neuronal \u03b3-secretase regulates lipid metabolism, linking cholesterol to synaptic dysfunction in Alzheimer\u2019s disease. Neuron 3176\u20133194.e3177. https:\/\/doi.org\/10.1016\/j.neuron.2023.07.005","DOI":"10.1016\/j.neuron.2023.07.005"},{"key":"4672_CR43","doi-asserted-by":"publisher","unstructured":"Carroll RC, Beattie EC, Von Zastrow M, Malenka RC (2001) Role of AMPA receptor endocytosis in synaptic plasticity. Nat Rev Neurosci 315\u2013324. https:\/\/doi.org\/10.1038\/35072500","DOI":"10.1038\/35072500"},{"key":"4672_CR44","doi-asserted-by":"publisher","unstructured":"Hering H, Lin CC, Sheng M (2003) Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J Neurosci 3262\u20133271. https:\/\/doi.org\/10.1523\/jneurosci.23-08-03262.2003","DOI":"10.1523\/jneurosci.23-08-03262.2003"},{"key":"4672_CR45","doi-asserted-by":"publisher","unstructured":"Korinek M, Gonzalez-Gonzalez I M, Smejkalova T, Hajdukovic D, Skrenkova K, Krusek J et al (2020) Cholesterol modulates presynaptic and postsynaptic properties of excitatory synaptic transmission. Sci Rep 12651. https:\/\/doi.org\/10.1038\/s41598-020-69454-5","DOI":"10.1038\/s41598-020-69454-5"},{"key":"4672_CR46","doi-asserted-by":"publisher","unstructured":"Pfrieger FW (2003) Role of cholesterol in synapse formation and function. Biochim Biophys Acta 271\u2013280. https:\/\/doi.org\/10.1016\/s0005-2736(03)00024-5","DOI":"10.1016\/s0005-2736(03)00024-5"},{"key":"4672_CR47","doi-asserted-by":"publisher","unstructured":"Puchkov D, Haucke V (2013) Greasing the synaptic vesicle cycle by membrane lipids. Trends Cell Biol 493\u2013503. https:\/\/doi.org\/10.1016\/j.tcb.2013.05.002","DOI":"10.1016\/j.tcb.2013.05.002"},{"key":"4672_CR48","doi-asserted-by":"publisher","unstructured":"Bruckner RJ, Mansy SS, Ricardo A, Mahadevan L, Szostak JW (2009) Flip-flop-induced relaxation of bending energy: implications for membrane remodeling. Biophys J 3113\u20133122. https:\/\/doi.org\/10.1016\/j.bpj.2009.09.025","DOI":"10.1016\/j.bpj.2009.09.025"},{"key":"4672_CR49","doi-asserted-by":"publisher","unstructured":"Binotti B, Jahn R, P\u00e9rez-Lara \u00c1 (2021) An overview of the synaptic vesicle lipid composition. Arch Biochem Biophys 108966. https:\/\/doi.org\/10.1016\/j.abb.2021.108966","DOI":"10.1016\/j.abb.2021.108966"},{"key":"4672_CR50","doi-asserted-by":"publisher","unstructured":"Aeffner S, Reusch T, Weinhausen B, Salditt T (2012) Energetics of stalk intermediates in membrane fusion are controlled by lipid composition. Proc Natl Acad Sci U S A E1609\u20131618. https:\/\/doi.org\/10.1073\/pnas.1119442109","DOI":"10.1073\/pnas.1119442109"},{"key":"4672_CR51","doi-asserted-by":"publisher","unstructured":"Ullian EM, Sapperstein SK, Christopherson KS, Barres BA (2001) Control of synapse number by glia. Science 657\u2013661. https:\/\/doi.org\/10.1126\/science.291.5504.657","DOI":"10.1126\/science.291.5504.657"},{"key":"4672_CR52","doi-asserted-by":"publisher","unstructured":"Pfrieger FW (2003) Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes?. Bioessays 72\u201378. https:\/\/doi.org\/10.1002\/bies.10195","DOI":"10.1002\/bies.10195"},{"key":"4672_CR53","doi-asserted-by":"publisher","unstructured":"Dietschy JM (2009) Central nervous system: cholesterol turnover, brain development and neurodegeneration. Biol Chem 287\u2013293. https:\/\/doi.org\/10.1515\/bc.2009.035","DOI":"10.1515\/bc.2009.035"},{"key":"4672_CR54","doi-asserted-by":"publisher","unstructured":"Norton WT, Poduslo SE (1973) Myelination in rat brain: changes in myelin composition during brain maturation. J Neurochem 759\u2013773. https:\/\/doi.org\/10.1111\/j.1471-4159.1973.tb07520.x","DOI":"10.1111\/j.1471-4159.1973.tb07520.x"},{"key":"4672_CR55","doi-asserted-by":"publisher","unstructured":"Mathews ES, Appel B (2016) Cholesterol biosynthesis supports myelin gene expression and axon ensheathment through modulation of P13K\/Akt\/mTor signaling. J Neurosci 7628\u20137639. https:\/\/doi.org\/10.1523\/jneurosci.0726-16.2016","DOI":"10.1523\/jneurosci.0726-16.2016"},{"key":"4672_CR56","doi-asserted-by":"publisher","unstructured":"Valenza M, Cattaneo E (2011) Emerging roles for cholesterol in Huntington\u2019s disease. Trends Neurosci 474\u2013486. https:\/\/doi.org\/10.1016\/j.tins.2011.06.005","DOI":"10.1016\/j.tins.2011.06.005"},{"key":"4672_CR57","doi-asserted-by":"publisher","unstructured":"Blanchard JW, Akay LA, Davila-Velderrain J, von Maydell D, Mathys H, Davidson SM et al (2022) APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature 769\u2013779. https:\/\/doi.org\/10.1038\/s41586-022-05439-w","DOI":"10.1038\/s41586-022-05439-w"},{"key":"4672_CR58","doi-asserted-by":"publisher","unstructured":"Itoh N, Itoh Y, Tassoni A, Ren E, Kaito M, Ohno A et al (2018) Cell-specific and region-specific transcriptomics in the multiple sclerosis model: focus on astrocytes. Proc Natl Acad Sci U S A E302-e309. https:\/\/doi.org\/10.1073\/pnas.1716032115","DOI":"10.1073\/pnas.1716032115"},{"key":"4672_CR59","doi-asserted-by":"publisher","unstructured":"Saher G, Br\u00fcgger B, Lappe-Siefke C, M\u00f6bius W, Tozawa R, Wehr MC et al (2005) High cholesterol level is essential for myelin membrane growth. Nat Neurosci 468\u2013475. https:\/\/doi.org\/10.1038\/nn1426","DOI":"10.1038\/nn1426"},{"key":"4672_CR60","doi-asserted-by":"publisher","unstructured":"Molina-Gonzalez I, Holloway RK, Jiwaji Z, Dando O, Kent SA, Emelianova K et al (2023) Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration. Nat Commun 3372. https:\/\/doi.org\/10.1038\/s41467-023-39046-8","DOI":"10.1038\/s41467-023-39046-8"},{"key":"4672_CR61","doi-asserted-by":"publisher","unstructured":"Li D, Zhang J, Liu Q (2022) Brain cell type-specific cholesterol metabolism and implications for learning and memory. Trends Neurosci 401\u2013414. https:\/\/doi.org\/10.1016\/j.tins.2022.01.002","DOI":"10.1016\/j.tins.2022.01.002"},{"key":"4672_CR62","doi-asserted-by":"publisher","unstructured":"Karch CM, Goate AM (2015) Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 43\u201351. https:\/\/doi.org\/10.1016\/j.biopsych.2014.05.006","DOI":"10.1016\/j.biopsych.2014.05.006"},{"key":"4672_CR63","doi-asserted-by":"publisher","unstructured":"Loera-Valencia R, Goikolea J, Parrado-Fernandez C, Merino-Serrais P, Maioli S (2019) Alterations in cholesterol metabolism as a risk factor for developing Alzheimer\u2019s disease: potential novel targets for treatment. J Steroid Biochem Mol Biol 104\u2013114. https:\/\/doi.org\/10.1016\/j.jsbmb.2019.03.003","DOI":"10.1016\/j.jsbmb.2019.03.003"},{"key":"4672_CR64","doi-asserted-by":"publisher","unstructured":"Barbero-Camps E, Fern\u00e1ndez A, Mart\u00ednez L, Fern\u00e1ndez-Checa JC, Colell A (2013) APP\/PS1 mice overexpressing SREBP-2 exhibit combined A\u03b2 accumulation and tau pathology underlying Alzheimer\u2019s disease. Hum Mol Genet 3460\u20133476. https:\/\/doi.org\/10.1093\/hmg\/ddt201","DOI":"10.1093\/hmg\/ddt201"},{"key":"4672_CR65","doi-asserted-by":"publisher","unstructured":"Lazar AN, Bich C, Panchal M, Desbenoit N, Petit VW, Touboul D et al (2013) Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients. Acta Neuropathol 133\u2013144. https:\/\/doi.org\/10.1007\/s00401-012-1041-1","DOI":"10.1007\/s00401-012-1041-1"},{"key":"4672_CR66","doi-asserted-by":"publisher","unstructured":"Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F (2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc Natl Acad Sci U S A 5815\u20135820. https:\/\/doi.org\/10.1073\/pnas.081612998","DOI":"10.1073\/pnas.081612998"},{"key":"4672_CR67","doi-asserted-by":"publisher","unstructured":"Seubert P, Oltersdorf T, Lee MG, Barbour R, Blomquist C, Davis DL et al (1993) Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature 260\u2013263. https:\/\/doi.org\/10.1038\/361260a0","DOI":"10.1038\/361260a0"},{"key":"4672_CR68","doi-asserted-by":"publisher","unstructured":"Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 569\u2013572. https:\/\/doi.org\/10.1038\/42408","DOI":"10.1038\/42408"},{"key":"4672_CR69","doi-asserted-by":"publisher","unstructured":"Bhattacharyya R, Barren C, Kovacs DM (2013) Palmitoylation of amyloid precursor protein regulates amyloidogenic processing in lipid rafts. J Neurosci 11169\u201311183. https:\/\/doi.org\/10.1523\/jneurosci.4704-12.2013","DOI":"10.1523\/jneurosci.4704-12.2013"},{"key":"4672_CR70","doi-asserted-by":"publisher","unstructured":"Hur JY, Welander H, Behbahani H, Aoki M, Fr\u00e5nberg J, Winblad B et al (2008) Active gamma-secretase is localized to detergent-resistant membranes in human brain. Febs J 1174\u20131187. https:\/\/doi.org\/10.1111\/j.1742-4658.2008.06278.x","DOI":"10.1111\/j.1742-4658.2008.06278.x"},{"key":"4672_CR71","doi-asserted-by":"publisher","unstructured":"Cho YY, Kwon OH, Park MK, Kim TW, Chung S (2019) Elevated cellular cholesterol in Familial Alzheimer\u2019s presenilin 1 mutation is associated with lipid raft localization of \u03b2-amyloid precursor protein. PLoS One e0210535. https:\/\/doi.org\/10.1371\/journal.pone.0210535","DOI":"10.1371\/journal.pone.0210535"},{"key":"4672_CR72","doi-asserted-by":"publisher","unstructured":"Barrett PJ, Song Y, Van Horn WD, Hustedt EJ, Schafer JM, Hadziselimovic A et al (2012) The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol. Science 1168\u20131171. https:\/\/doi.org\/10.1126\/science.1219988","DOI":"10.1126\/science.1219988"},{"key":"4672_CR73","doi-asserted-by":"publisher","unstructured":"Cordy JM, Hussain I, Dingwall C, Hooper NM, Turner AJ (2003) Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc Natl Acad Sci U S A 11735\u201311740. https:\/\/doi.org\/10.1073\/pnas.1635130100","DOI":"10.1073\/pnas.1635130100"},{"key":"4672_CR74","doi-asserted-by":"publisher","unstructured":"Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A 6460\u20136464. https:\/\/doi.org\/10.1073\/pnas.95.11.6460","DOI":"10.1073\/pnas.95.11.6460"},{"key":"4672_CR75","doi-asserted-by":"publisher","unstructured":"Wang H, Kulas JA, Wang C, Holtzman DM, Ferris HA, Hansen SB (2021) Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol. Proc Natl Acad Sci U S A https:\/\/doi.org\/10.1073\/pnas.2102191118","DOI":"10.1073\/pnas.2102191118"},{"key":"4672_CR76","doi-asserted-by":"publisher","unstructured":"Bhattacharyya R, Kovacs DM (2010) ACAT inhibition and amyloid beta reduction. Biochim Biophys Acta 960\u2013965. https:\/\/doi.org\/10.1016\/j.bbalip.2010.04.003","DOI":"10.1016\/j.bbalip.2010.04.003"},{"key":"4672_CR77","doi-asserted-by":"publisher","unstructured":"Azizidoost S, Babaahmadi-Rezaei H, Nazeri Z, Cheraghzadeh M, Kheirollah A (2022) Amyloid beta increases ABCA1 and HMGCR protein expression, and cholesterol synthesis and accumulation in mice neurons and astrocytes. Biochim Biophys Acta Mol Cell Biol Lipids 159069. https:\/\/doi.org\/10.1016\/j.bbalip.2021.159069","DOI":"10.1016\/j.bbalip.2021.159069"},{"key":"4672_CR78","doi-asserted-by":"publisher","unstructured":"Mohamed A, Viveiros A, Williams K, Posse de Chaves E (2018) A\u03b2 inhibits SREBP-2 activation through Akt inhibition. J Lipid Res 1\u201313. https:\/\/doi.org\/10.1194\/jlr.M076703","DOI":"10.1194\/jlr.M076703"},{"key":"4672_CR79","doi-asserted-by":"publisher","unstructured":"Distl R, Meske V, Ohm T G (2001) Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons. Acta Neuropathol 547\u2013554. https:\/\/doi.org\/10.1007\/s004010000314","DOI":"10.1007\/s004010000314"},{"key":"4672_CR80","doi-asserted-by":"publisher","unstructured":"Zhou X, Xu J (2012) Free cholesterol induces higher \u03b2-sheet content in A\u03b2 peptide oligomers by aromatic interaction with Phe19. PLoS One e46245. https:\/\/doi.org\/10.1371\/journal.pone.0046245","DOI":"10.1371\/journal.pone.0046245"},{"key":"4672_CR81","doi-asserted-by":"publisher","unstructured":"Takano K, Endo S, Mukaiyama A, Chon H, Matsumura H, Koga Y et al (2006) Structure of amyloid beta fragments in aqueous environments. Febs J 150\u2013158. https:\/\/doi.org\/10.1111\/j.1742-4658.2005.05051.x","DOI":"10.1111\/j.1742-4658.2005.05051.x"},{"key":"4672_CR82","doi-asserted-by":"publisher","unstructured":"Banerjee S, Hashemi M, Zagorski K, Lyubchenko YL (2021) Cholesterol in membranes facilitates aggregation of amyloid \u03b2 protein at physiologically relevant concentrations. ACS Chem Neurosci 506\u2013516. https:\/\/doi.org\/10.1021\/acschemneuro.0c00688","DOI":"10.1021\/acschemneuro.0c00688"},{"key":"4672_CR83","doi-asserted-by":"publisher","unstructured":"Stewart KL, Radford SE (2017) Amyloid plaques beyond A\u03b2: a survey of the diverse modulators of amyloid aggregation. Biophys Rev 405\u2013419. https:\/\/doi.org\/10.1007\/s12551-017-0271-9","DOI":"10.1007\/s12551-017-0271-9"},{"key":"4672_CR84","doi-asserted-by":"publisher","unstructured":"van der Kant R, Langness VF, Herrera CM, Williams DA, Fong LK, Leestemaker Y et al (2019) Cholesterol metabolism is a druggable axis that independently regulates tau and amyloid-\u03b2 in iPSC-derived Alzheimer\u2019s disease neurons. Cell Stem Cell 363-375.e369. https:\/\/doi.org\/10.1016\/j.stem.2018.12.013","DOI":"10.1016\/j.stem.2018.12.013"},{"key":"4672_CR85","doi-asserted-by":"publisher","unstructured":"Eftekharzadeh B, Daigle JG, Kapinos LE, Coyne A, Schiantarelli J, Carlomagno Y et al (2018) Tau protein disrupts nucleocytoplasmic transport in Alzheime\u2019s disease. Neuron 925\u2013940.e927. https:\/\/doi.org\/10.1016\/j.neuron.2018.07.039","DOI":"10.1016\/j.neuron.2018.07.039"},{"key":"4672_CR86","doi-asserted-by":"publisher","unstructured":"Shibuya Y, Niu Z, Bryleva EY, Harris BT, Murphy SR, Kheirollah A et al (2015) Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer\u2019s disease mouse and reduces human P301L-tau content at the presymptomatic stage. Neurobiol Aging 2248\u20132259. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.04.002","DOI":"10.1016\/j.neurobiolaging.2015.04.002"},{"key":"4672_CR87","doi-asserted-by":"publisher","unstructured":"Marchi N, Banjara M, Janigro D (2016) Blood-brain barrier, bulk flow, and interstitial clearance in epilepsy. J Neurosci Methods 118\u2013124. https:\/\/doi.org\/10.1016\/j.jneumeth.2015.06.011","DOI":"10.1016\/j.jneumeth.2015.06.011"},{"key":"4672_CR88","doi-asserted-by":"publisher","unstructured":"Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer\u2019s disease. Acta Neuropathol 103\u2013113. https:\/\/doi.org\/10.1007\/s00401-009-0522-3","DOI":"10.1007\/s00401-009-0522-3"},{"key":"4672_CR89","doi-asserted-by":"publisher","unstructured":"Gali CC, Fanaee-Danesh E, Zandl-Lang M, Albrecher NM, Tam-Amersdorfer C, Stracke A et al (2019) Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-\u03b2 in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice. Mol Cell Neurosci 103390. https:\/\/doi.org\/10.1016\/j.mcn.2019.103390","DOI":"10.1016\/j.mcn.2019.103390"},{"key":"4672_CR90","doi-asserted-by":"publisher","unstructured":"Jaeger LB, Dohgu S, Hwang MC, Farr SA, Murphy MP, Fleegal-Demotta MA et al (2009) Testing the neurovascular hypothesis of Alzheimer\u2019s disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition. J Alzheimers Dis 553\u2013570. https:\/\/doi.org\/10.3233\/jad-2009-1074","DOI":"10.3233\/jad-2009-1074"},{"key":"4672_CR91","doi-asserted-by":"publisher","unstructured":"Tamamizu-Kato S, Cohen JK, Drake CB, Kosaraju MG, Drury J, Narayanaswami V (2008) Interaction with amyloid beta peptide compromises the lipid binding function of apolipoprotein E. Biochemistry 5225\u20135234. https:\/\/doi.org\/10.1021\/bi702097s","DOI":"10.1021\/bi702097s"},{"key":"4672_CR92","doi-asserted-by":"publisher","unstructured":"Wisniewski T, Frangione B (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 235\u2013238. https:\/\/doi.org\/10.1016\/0304-3940(92)90444-c","DOI":"10.1016\/0304-3940(92)90444-c"},{"key":"4672_CR93","doi-asserted-by":"publisher","unstructured":"Belloy ME, Napolioni V, Greicius MD (2019) A quarter century of APOE and Alzheimer\u2019s disease: progress to date and the path forward. Neuron 820\u2013838. https:\/\/doi.org\/10.1016\/j.neuron.2019.01.056","DOI":"10.1016\/j.neuron.2019.01.056"},{"key":"4672_CR94","doi-asserted-by":"publisher","unstructured":"Serrano-Pozo A, Das S, Hyman BT (2021) APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol 68\u201380. https:\/\/doi.org\/10.1016\/s1474-4422(20)30412-9","DOI":"10.1016\/s1474-4422(20)30412-9"},{"key":"4672_CR95","doi-asserted-by":"publisher","unstructured":"Castellano JM, Kim J, Stewart FR, Jiang H, Demattos RB, Patterson BW et al (2011) Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci Transl Med 89ra57. https:\/\/doi.org\/10.1126\/scitranslmed.3002156","DOI":"10.1126\/scitranslmed.3002156"},{"key":"4672_CR96","doi-asserted-by":"publisher","unstructured":"Wang C, Xiong M, Gratuze M, Bao X, Shi Y, Andhey PS et al (2021) Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron 1657\u20131674.e1657. https:\/\/doi.org\/10.1016\/j.neuron.2021.03.024","DOI":"10.1016\/j.neuron.2021.03.024"},{"key":"4672_CR97","doi-asserted-by":"publisher","unstructured":"Sobo K, Le Blanc I, Luyet PP, Fivaz M, Ferguson C, Parton RG et al (2007) Late endosomal cholesterol accumulation leads to impaired intra-endosomal trafficking. PLoS One e851. https:\/\/doi.org\/10.1371\/journal.pone.0000851","DOI":"10.1371\/journal.pone.0000851"},{"key":"4672_CR98","doi-asserted-by":"publisher","unstructured":"Barbero-Camps E, Roca-Agujetas V, Bartolessis I, de Dios C, Fern\u00e1ndez-Checa JC, Mar\u00ed M et al (2018) Cholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion. Autophagy 1129\u20131154. https:\/\/doi.org\/10.1080\/15548627.2018.1438807","DOI":"10.1080\/15548627.2018.1438807"},{"key":"4672_CR99","doi-asserted-by":"publisher","unstructured":"Lee CY, Tse W, Smith JD, Landreth GE (2012) Apolipoprotein E promotes \u03b2-amyloid trafficking and degradation by modulating microglial cholesterol levels. J Biol Chem 2032\u20132044. https:\/\/doi.org\/10.1074\/jbc.M111.295451","DOI":"10.1074\/jbc.M111.295451"},{"key":"4672_CR100","doi-asserted-by":"publisher","unstructured":"Eckman EA, Eckman CB (2005) Abeta-degrading enzymes: modulators of Alzheimer\u2019s disease pathogenesis and targets for therapeutic intervention. Biochem Soc Trans 1101\u20131105. https:\/\/doi.org\/10.1042\/bst20051101","DOI":"10.1042\/bst20051101"},{"key":"4672_CR101","doi-asserted-by":"publisher","unstructured":"Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, Love S (2008) Abeta-degrading enzymes in Alzheimer\u2019s disease. Brain Pathol 240\u2013252. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00132.x","DOI":"10.1111\/j.1750-3639.2008.00132.x"},{"key":"4672_CR102","doi-asserted-by":"publisher","unstructured":"Maulik M, Westaway D, Jhamandas JH, Kar S (2013) Role of cholesterol in APP metabolism and its significance in Alzheimer\u2019s disease pathogenesis. Mol Neurobiol 37\u201363. https:\/\/doi.org\/10.1007\/s12035-012-8337-y","DOI":"10.1007\/s12035-012-8337-y"},{"key":"4672_CR103","doi-asserted-by":"publisher","unstructured":"Ledesma MD, Abad-Rodriguez J, Galvan C, Biondi E, Navarro P, Delacourte A et al (2003) Raft disorganization leads to reduced plasmin activity in Alzheimer\u2019s disease brains. EMBO Rep 1190\u20131196. https:\/\/doi.org\/10.1038\/sj.embor.7400021","DOI":"10.1038\/sj.embor.7400021"},{"key":"4672_CR104","doi-asserted-by":"publisher","unstructured":"Basak JM, Verghese PB, Yoon H, Kim J, Holtzman DM (2012) Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of A\u03b2 uptake and degradation by astrocytes. J Biol Chem 13959\u201313971. https:\/\/doi.org\/10.1074\/jbc.M111.288746","DOI":"10.1074\/jbc.M111.288746"},{"key":"4672_CR105","doi-asserted-by":"publisher","unstructured":"Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A et al (2013) ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal apoE\/A\u03b2 association in physiological conditions. Proc Natl Acad Sci U S A E1807\u20131816. https:\/\/doi.org\/10.1073\/pnas.1220484110","DOI":"10.1073\/pnas.1220484110"},{"key":"4672_CR106","doi-asserted-by":"publisher","unstructured":"Prasad H, Rao R (2018) Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH. Proc Natl Acad Sci U S A E6640-E6649. https:\/\/doi.org\/10.1073\/pnas.1801612115","DOI":"10.1073\/pnas.1801612115"},{"key":"4672_CR107","doi-asserted-by":"publisher","unstructured":"Hara M, Matsushima T, Satoh H, Iso-o N, Noto H, Togo M et al (2003) Isoform-dependent cholesterol efflux from macrophages by apolipoprotein E is modulated by cell surface proteoglycans. Arterioscler Thromb Vasc Biol 269\u2013274. https:\/\/doi.org\/10.1161\/01.atv.0000054199.78458.4b","DOI":"10.1161\/01.atv.0000054199.78458.4b"},{"key":"4672_CR108","doi-asserted-by":"publisher","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC et al (2019) Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet 414\u2013430. https:\/\/doi.org\/10.1038\/s41588-019-0358-2","DOI":"10.1038\/s41588-019-0358-2"},{"key":"4672_CR109","doi-asserted-by":"publisher","unstructured":"Yeh FL, Wang Y, Tom I, Gonzalez LC, Sheng M (2016) TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 328\u2013340. https:\/\/doi.org\/10.1016\/j.neuron.2016.06.015","DOI":"10.1016\/j.neuron.2016.06.015"},{"key":"4672_CR110","doi-asserted-by":"publisher","unstructured":"Lee CYD, Daggett A, Gu X, Jiang LL, Langfelder P, Li X et al (2018) Elevated TREM2 gene dosage reprograms microglia responsivity and ameliorates pathological phenotypes in Alzheimer\u2019s disease models. Neuron 1032\u20131048.e1035. https:\/\/doi.org\/10.1016\/j.neuron.2018.02.002","DOI":"10.1016\/j.neuron.2018.02.002"},{"key":"4672_CR111","doi-asserted-by":"publisher","unstructured":"Wang S, Sudan R, Peng V, Zhou Y, Du S, Yuede CM et al (2022) TREM2 drives microglia response to amyloid-\u03b2 via SYK-dependent and -independent pathways. Cell 4153\u20134169.e4119. https:\/\/doi.org\/10.1016\/j.cell.2022.09.033","DOI":"10.1016\/j.cell.2022.09.033"},{"key":"4672_CR112","doi-asserted-by":"publisher","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK et al (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 1276\u20131290.e1217. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018","DOI":"10.1016\/j.cell.2017.05.018"},{"key":"4672_CR113","doi-asserted-by":"publisher","unstructured":"Bemiller SM, Mccray TJ, Allan K, Formica SV, Xu G, Wilson G et al (2017) TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy. Mol Neurodegener 74. https:\/\/doi.org\/10.1186\/s13024-017-0216-6","DOI":"10.1186\/s13024-017-0216-6"},{"key":"4672_CR114","doi-asserted-by":"publisher","unstructured":"Sayed FA, Telpoukhovskaia M, Kodama L, Li Y, Zhou Y, Le D et al (2018) Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy. Proc Natl Acad Sci U S A 10172\u201310177. https:\/\/doi.org\/10.1073\/pnas.1811411115","DOI":"10.1073\/pnas.1811411115"},{"key":"4672_CR115","doi-asserted-by":"publisher","unstructured":"Li RY, Qin Q, Yang HC, Wang YY, Mi YX, Yin YS et al (2022) TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target. Mol Neurodegener 40. https:\/\/doi.org\/10.1186\/s13024-022-00542-y","DOI":"10.1186\/s13024-022-00542-y"},{"key":"4672_CR116","doi-asserted-by":"publisher","unstructured":"Sakae N, Liu CC, Shinohara M, Frisch-Daiello J, Ma L, Yamazaki Y et al (2016) ABCA7 deficiency accelerates amyloid-\u03b2 generation and Alzheimer\u2019s neuronal pathology. J Neurosci 3848\u20133859. https:\/\/doi.org\/10.1523\/jneurosci.3757-15.2016","DOI":"10.1523\/jneurosci.3757-15.2016"},{"key":"4672_CR117","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez A, Llacuna L, Fern\u00e1ndez-Checa JC, Colell A (2009) Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity. J Neurosci 6394\u20136405. https:\/\/doi.org\/10.1523\/jneurosci.4909-08.2009","DOI":"10.1523\/jneurosci.4909-08.2009"},{"key":"4672_CR118","doi-asserted-by":"publisher","unstructured":"Marquer C, Devauges V, Cossec JC, Liot G, L\u00e9cart S, Saudou F et al (2011) Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis. Faseb J 1295\u20131305. https:\/\/doi.org\/10.1096\/fj.10-168633","DOI":"10.1096\/fj.10-168633"},{"key":"4672_CR119","doi-asserted-by":"publisher","unstructured":"Zelcer N, Khanlou N, Clare R, Jiang Q, Reed-Geaghan EG, Landreth GE et al (2007) Attenuation of neuroinflammation and Alzheimer\u2019s disease pathology by liver x receptors. Proc Natl Acad Sci U S A 10601\u201310606. https:\/\/doi.org\/10.1073\/pnas.0701096104","DOI":"10.1073\/pnas.0701096104"},{"key":"4672_CR120","doi-asserted-by":"publisher","unstructured":"Shah SA, Yoon GH, Chung SS, Abid MN, Kim TH, Lee HY et al (2017) Novel osmotin inhibits SREBP2 via the AdipoR1\/AMPK\/SIRT1 pathway to improve Alzheimer\u2019s disease neuropathological deficits. Mol Psychiatry 407\u2013416. https:\/\/doi.org\/10.1038\/mp.2016.23","DOI":"10.1038\/mp.2016.23"},{"key":"4672_CR121","doi-asserted-by":"publisher","unstructured":"Zhong M, Xu QQ, Hu Z, Yang W, Lin ZX, Xian YF (2024) Tianma-Gouteng pair ameliorates the cognitive deficits on two transgenic mouse models of Alzheimer\u2019s disease. J Ethnopharmacol 118113. https:\/\/doi.org\/10.1016\/j.jep.2024.118113","DOI":"10.1016\/j.jep.2024.118113"},{"key":"4672_CR122","doi-asserted-by":"publisher","unstructured":"Chen J, Li Y, Chen M, Liu X, Chen J, Li X et al (2023) Pantethine ameliorates recognition impairment in a mouse model of Alzheimer\u2019s disease by modulating cholesterol content and intestinal flora species. Mol Nutr Food Res e2200799. https:\/\/doi.org\/10.1002\/mnfr.202200799","DOI":"10.1002\/mnfr.202200799"},{"key":"4672_CR123","doi-asserted-by":"publisher","unstructured":"Fan YG, Guo T, Han XR, Liu JL, Cai YT, Xue H et al (2019) Paricalcitol accelerates BACE1 lysosomal degradation and inhibits calpain-1 dependent neuronal loss in APP\/PS1 transgenic mice. EBioMedicine 393\u2013407. https:\/\/doi.org\/10.1016\/j.ebiom.2019.07.014","DOI":"10.1016\/j.ebiom.2019.07.014"},{"key":"4672_CR124","doi-asserted-by":"publisher","unstructured":"Mastrocola R, Guglielmotto M, Medana C, Catalano MG, Cutrupi S, Borghi R et al (2011) Dysregulation of SREBP2 induces BACE1 expression. Neurobiol Dis 116\u2013124. https:\/\/doi.org\/10.1016\/j.nbd.2011.06.010","DOI":"10.1016\/j.nbd.2011.06.010"},{"key":"4672_CR125","doi-asserted-by":"publisher","unstructured":"Sandoval-Hern\u00e1ndez AG, Buitrago L, Moreno H, Cardona-G\u00f3mez GP, Arboleda G (2016) Role of liver X receptor in AD pathophysiology. PLOS ONE e0145467. https:\/\/doi.org\/10.1371\/journal.pone.0145467","DOI":"10.1371\/journal.pone.0145467"},{"key":"4672_CR126","doi-asserted-by":"publisher","unstructured":"Vanmierlo T, Rutten K, Dederen J, Bloks VW, van Vark-van der Zee LC, Kuipers F et al (2011) Liver X receptor activation restores memory in aged AD mice without reducing amyloid. Neurobiol Aging 1262\u20131272. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.07.005","DOI":"10.1016\/j.neurobiolaging.2009.07.005"},{"key":"4672_CR127","doi-asserted-by":"publisher","unstructured":"Wahrle S E, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD et al (2004) ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem 40987\u201340993. https:\/\/doi.org\/10.1074\/jbc.M407963200","DOI":"10.1074\/jbc.M407963200"},{"key":"4672_CR128","doi-asserted-by":"publisher","unstructured":"Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, Zelcer N et al (2008) ApoE promotes the proteolytic degradation of Abeta. Neuron 681\u2013693. https:\/\/doi.org\/10.1016\/j.neuron.2008.04.010","DOI":"10.1016\/j.neuron.2008.04.010"},{"key":"4672_CR129","doi-asserted-by":"publisher","unstructured":"Vanmierlo T, Rutten K, Dederen J, Bloks VW, van Vark-van der Zee LC, KUIPERS Fet al.(2011) Liver X receptor activation restores memory in aged AD mice without reducing amyloid. Neurobiol Aging 1262\u20131272. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.07.005","DOI":"10.1016\/j.neurobiolaging.2009.07.005"},{"key":"4672_CR130","doi-asserted-by":"publisher","unstructured":"Litvinchuk A, Suh JH, Guo JL, Lin K, Davis SS, Bien-Ly N et al (2024) Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist. Neuron 384\u2013403.e388. https:\/\/doi.org\/10.1016\/j.neuron.2023.10.023","DOI":"10.1016\/j.neuron.2023.10.023"},{"key":"4672_CR131","doi-asserted-by":"publisher","unstructured":"Sandoval-Hern\u00e1ndez AG, Buitrago L, Moreno H, Cardona-G\u00f3mez GP, Arboleda G (2015) Role of liver X receptor in AD pathophysiology. PLoS One e0145467. https:\/\/doi.org\/10.1371\/journal.pone.0145467","DOI":"10.1371\/journal.pone.0145467"},{"key":"4672_CR132","doi-asserted-by":"publisher","unstructured":"B\u00e1ez-Becerra C, Filipello F, Sandoval-Hern\u00e1ndez A, Arboleda H, Arboleda G (2018) Liver X receptor agonist GW3965 regulates synaptic function upon amyloid beta exposure in hippocampal neurons. Neurotox Res 569\u2013579. https:\/\/doi.org\/10.1007\/s12640-017-9845-3","DOI":"10.1007\/s12640-017-9845-3"},{"key":"4672_CR133","doi-asserted-by":"publisher","unstructured":"Fonseca R, N\u00e4gerl UV, Bonhoeffer T (2006) Neuronal activity determines the protein synthesis dependence of long-term potentiation. Nat Neurosci 478\u2013480. https:\/\/doi.org\/10.1038\/nn1667","DOI":"10.1038\/nn1667"},{"key":"4672_CR134","doi-asserted-by":"publisher","unstructured":"Choi J, Gao J, Kim J, Hong C, Kim J, Tontonoz P (2015) The E3 ubiquitin ligase Idol controls brain LDL receptor expression, ApoE clearance, and A\u03b2 amyloidosis. Sci Transl Med 314ra184. https:\/\/doi.org\/10.1126\/scitranslmed.aad1904","DOI":"10.1126\/scitranslmed.aad1904"},{"key":"4672_CR135","doi-asserted-by":"publisher","unstructured":"Tabrizi SJ, Estevez-Fraga C, van Roon-Mom WMC, Flower MD, Scahill RI, Wild EJ et al (2022) Potential disease-modifying therapies for Huntington\u2019s disease: lessons learned and future opportunities. Lancet Neurol 645\u2013658. https:\/\/doi.org\/10.1016\/s1474-4422(22)00121-1","DOI":"10.1016\/s1474-4422(22)00121-1"},{"key":"4672_CR136","doi-asserted-by":"publisher","unstructured":"Li H, Li S H, Johnston H, Shelbourne PF, Li XJ (2000) Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nat Genet 385\u2013389. https:\/\/doi.org\/10.1038\/78054","DOI":"10.1038\/78054"},{"key":"4672_CR137","doi-asserted-by":"publisher","unstructured":"Xiang Z, Valenza M, Cui L, Leoni V, Jeong HK, Brilli E et al (2011) Peroxisome-proliferator-activated receptor gamma coactivator 1 \u03b1 contributes to dysmyelination in experimental models of Huntington's disease. J Neurosci 9544\u20139553. https:\/\/doi.org\/10.1523\/jneurosci.1291-11.2011","DOI":"10.1523\/jneurosci.1291-11.2011"},{"key":"4672_CR138","doi-asserted-by":"publisher","unstructured":"Valenza M, Leoni V, Karasinska JM, Petricca L, Fan J, Carroll J et al (2010) Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes. J Neurosci 10844\u201310850. https:\/\/doi.org\/10.1523\/jneurosci.0917-10.2010","DOI":"10.1523\/jneurosci.0917-10.2010"},{"key":"4672_CR139","doi-asserted-by":"publisher","unstructured":"Futter M, Diekmann H, Schoenmakers E, Sadiq O, Chatterjee K, Rubinsztein DC (2009) Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors. J Med Genet 438\u2013446. https:\/\/doi.org\/10.1136\/jmg.2009.066399","DOI":"10.1136\/jmg.2009.066399"},{"key":"4672_CR140","doi-asserted-by":"publisher","unstructured":"Kacher R, Mounier C, Caboche J, Betuing S (2022) Altered cholesterol homeostasis in Huntington\u2019s disease. Front Aging Neurosci 797220. https:\/\/doi.org\/10.3389\/fnagi.2022.797220","DOI":"10.3389\/fnagi.2022.797220"},{"key":"4672_CR141","doi-asserted-by":"publisher","unstructured":"Trushina E, Singh RD, Dyer RB, Cao S, Shah VH, Parton RG et al (2006) Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo. Hum Mol Genet 3578\u20133591. https:\/\/doi.org\/10.1093\/hmg\/ddl434","DOI":"10.1093\/hmg\/ddl434"},{"key":"4672_CR142","doi-asserted-by":"publisher","unstructured":"Birolini G, Valenza M, Ottonelli I, Talpo F, Minoli L, Cappelleri A et al (2023) Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington\u2019s disease. Pharmacol Res 106823. https:\/\/doi.org\/10.1016\/j.phrs.2023.106823","DOI":"10.1016\/j.phrs.2023.106823"},{"key":"4672_CR143","doi-asserted-by":"publisher","unstructured":"Di Pardo A, Monyror J, Morales LC, Kadam V, Lingrell S, Maglione V et al (2020) Mutant huntingtin interacts with the sterol regulatory element-binding proteins and impairs their nuclear import. Hum Mol Genet 418\u2013431. https:\/\/doi.org\/10.1093\/hmg\/ddz298","DOI":"10.1093\/hmg\/ddz298"},{"key":"4672_CR144","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez-Guevara E, C\u00e1rdenas G, P\u00e9rez-Severiano F, Mart\u00ednez-Lazcano JC (2020) Dysregulated brain cholesterol metabolism is linked to neuroinflammation in Huntington\u2019s disease. Mov Disord 1113\u20131127. https:\/\/doi.org\/10.1002\/mds.28089","DOI":"10.1002\/mds.28089"},{"key":"4672_CR145","doi-asserted-by":"publisher","unstructured":"Mailleux J, Vanmierlo T, Bogie JF, Wouters E, L\u00fctjohann D, Hendriks JJ et al (2018) Active liver X receptor signaling in phagocytes in multiple sclerosis lesions. Mult Scler 279\u2013289. https:\/\/doi.org\/10.1177\/1352458517696595","DOI":"10.1177\/1352458517696595"},{"key":"4672_CR146","doi-asserted-by":"publisher","unstructured":"Valenza M, Marullo M, Di Paolo E, Cesana E, Zuccato C, Biella G et al (2015) Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington\u2019s disease. Cell Death Differ 690\u2013702. https:\/\/doi.org\/10.1038\/cdd.2014.162","DOI":"10.1038\/cdd.2014.162"},{"key":"4672_CR147","doi-asserted-by":"publisher","unstructured":"Valenza M, Birolini G, Cattaneo E (2023) The translational potential of cholesterol-based therapies for neurological disease. Nat Rev Neurol 583\u2013598. https:\/\/doi.org\/10.1038\/s41582-023-00864-5","DOI":"10.1038\/s41582-023-00864-5"},{"key":"4672_CR148","doi-asserted-by":"publisher","unstructured":"van Deijk AF, Camargo N, Timmerman J, Heistek T, Brouwers JF, Mogavero F et al (2017) Astrocyte lipid metabolism is critical for synapse development and function in vivo. Glia 670\u2013682. https:\/\/doi.org\/10.1002\/glia.23120","DOI":"10.1002\/glia.23120"},{"key":"4672_CR149","doi-asserted-by":"publisher","unstructured":"Birolini G, Verlengia G, Talpo F, Maniezzi C, Zentilin L, Giacca M et al (2021) SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington\u2019s disease phenotypes. Brain 3175\u20133190. https:\/\/doi.org\/10.1093\/brain\/awab186","DOI":"10.1093\/brain\/awab186"},{"key":"4672_CR150","doi-asserted-by":"publisher","unstructured":"Ferris HA, Perry RJ, Moreira GV, Shulman GI, Horton JD, Kahn CR (2017) Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism. Proc Natl Acad Sci U S A 1189\u20131194. https:\/\/doi.org\/10.1073\/pnas.1620506114","DOI":"10.1073\/pnas.1620506114"},{"key":"4672_CR151","doi-asserted-by":"publisher","unstructured":"Linetti A, Fratangeli A, Taverna E, Valnegri P, Francolini M, Cappello V et al (2010) Cholesterol reduction impairs exocytosis of synaptic vesicles. J Cell Sci 595\u2013605. https:\/\/doi.org\/10.1242\/jcs.060681","DOI":"10.1242\/jcs.060681"},{"key":"4672_CR152","doi-asserted-by":"publisher","unstructured":"Tarr PT, Edwards PA (2008) ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2. J Lipid Res 169\u2013182. https:\/\/doi.org\/10.1194\/jlr.M700364-JLR200","DOI":"10.1194\/jlr.M700364-JLR200"},{"key":"4672_CR153","doi-asserted-by":"publisher","unstructured":"Pinchaud K, Masson C, Dayre B, Mounier C, Gilles JF, Vanhoutte P et al (2023) Cell-type specific regulation of cholesterogenesis by CYP46A1 re-expression in zQ175 HD mouse striatum. Int J Mol Sci https:\/\/doi.org\/10.3390\/ijms241311001","DOI":"10.3390\/ijms241311001"},{"key":"4672_CR154","doi-asserted-by":"publisher","unstructured":"Boussicault L, Alves S, Lamazi\u00e8re A, Planques A, Heck N, Moumn\u00e9 L et al (2016) CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease. Brain 953\u2013970. https:\/\/doi.org\/10.1093\/brain\/awv384","DOI":"10.1093\/brain\/awv384"},{"key":"4672_CR155","doi-asserted-by":"publisher","unstructured":"Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S et al (2018) Multiple sclerosis. Nat Rev Dis Prim 43. https:\/\/doi.org\/10.1038\/s41572-018-0041-4","DOI":"10.1038\/s41572-018-0041-4"},{"key":"4672_CR156","doi-asserted-by":"publisher","unstructured":"Hes K, Starost L, Kieran NW, Thomas C, Vincenten MCJ, Antel J et al (2020) Lesion stage-dependent causes for impaired remyelination in MS. Acta Neuropathol 359\u2013375. https:\/\/doi.org\/10.1007\/s00401-020-02189-9","DOI":"10.1007\/s00401-020-02189-9"},{"key":"4672_CR157","doi-asserted-by":"crossref","unstructured":"Kuhn S, Gritti L, Crooks D, Dombrowski Y (2019) Oligodendrocytes in development, myelin generation and beyond. Cells 1424","DOI":"10.3390\/cells8111424"},{"key":"4672_CR158","doi-asserted-by":"publisher","unstructured":"Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H et al (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 500\u2013508. https:\/\/doi.org\/10.1038\/nm0502-500","DOI":"10.1038\/nm0502-500"},{"key":"4672_CR159","doi-asserted-by":"publisher","unstructured":"Berghoff S A, D\u00fcking T, Spieth L, Winchenbach J, Stumpf SK, Gerndt N et al (2017) Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model. Acta Neuropathol Commun 94. https:\/\/doi.org\/10.1186\/s40478-017-0497-6","DOI":"10.1186\/s40478-017-0497-6"},{"key":"4672_CR160","doi-asserted-by":"publisher","unstructured":"Berghoff SA, Spieth L, Saher G (2022) Local cholesterol metabolism orchestrates remyelination. Trends Neurosci 272\u2013283. https:\/\/doi.org\/10.1016\/j.tins.2022.01.001","DOI":"10.1016\/j.tins.2022.01.001"},{"key":"4672_CR161","doi-asserted-by":"publisher","unstructured":"Evangelopoulos ME, Koutsis G, Boufidou F, Markianos M (2022) Cholesterol levels in plasma and cerebrospinal fluid in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Neurobiol Dis 105889. https:\/\/doi.org\/10.1016\/j.nbd.2022.105889","DOI":"10.1016\/j.nbd.2022.105889"},{"key":"4672_CR162","doi-asserted-by":"publisher","unstructured":"Lavrnja I, Smiljanic K, Savic D, Mladenovic-Djordjevic A, Tesovic K, Kanazir S et al (2017) Expression profiles of cholesterol metabolism-related genes are altered during development of experimental autoimmune encephalomyelitis in the rat spinal cord. Sci Rep 2702. https:\/\/doi.org\/10.1038\/s41598-017-02638-8","DOI":"10.1038\/s41598-017-02638-8"},{"key":"4672_CR163","doi-asserted-by":"publisher","unstructured":"Leoni V, Masterman T, Diczfalusy U, De Luca G, Hillert J, Bj\u00f6rkhem I (2002) Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis. Neurosci Lett 163\u2013166. https:\/\/doi.org\/10.1016\/s0304-3940(02)00887-x","DOI":"10.1016\/s0304-3940(02)00887-x"},{"key":"4672_CR164","doi-asserted-by":"publisher","unstructured":"Wang Y, Muneton S, Sj\u00f6vall J, Jovanovic JN, Griffiths WJ (2008) The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron proteome. J Proteome Res 1606\u20131614. https:\/\/doi.org\/10.1021\/pr7006076","DOI":"10.1021\/pr7006076"},{"key":"4672_CR165","doi-asserted-by":"publisher","unstructured":"Berghoff SA, Gerndt N, Winchenbach J, Stumpf SK, Hosang L, Odoardi F et al (2017) Dietary cholesterol promotes repair of demyelinated lesions in the adult brain. Nat Commun 14241. https:\/\/doi.org\/10.1038\/ncomms14241","DOI":"10.1038\/ncomms14241"},{"key":"4672_CR166","doi-asserted-by":"publisher","unstructured":"Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J, Br\u00fcck W (2008) Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 1749\u20131758. https:\/\/doi.org\/10.1093\/brain\/awn096","DOI":"10.1093\/brain\/awn096"},{"key":"4672_CR167","doi-asserted-by":"publisher","unstructured":"Skripuletz T, Manzel A, Gropengiesse K, Sch\u00e4fer N, Gudi V, Singh V et al (2015) Pivotal role of choline metabolites in remyelination. Brain 398\u2013413. https:\/\/doi.org\/10.1093\/brain\/awu358","DOI":"10.1093\/brain\/awu358"},{"key":"4672_CR168","doi-asserted-by":"publisher","unstructured":"Van de Kraats C, Killestein J, Popescu V, Rijkers E, Vrenken H, L\u00fctjohann D et al (2014) Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis. Mult Scler 412\u2013417. https:\/\/doi.org\/10.1177\/1352458513499421","DOI":"10.1177\/1352458513499421"},{"key":"4672_CR169","doi-asserted-by":"publisher","unstructured":"Vuletic S, Kennedy H, Albers JJ, Killestein J, Vrenken H, L\u00fctjohann D et al (2014) Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables. Mult Scler Relat Disord 533\u2013541. https:\/\/doi.org\/10.1016\/j.msard.2014.01.004","DOI":"10.1016\/j.msard.2014.01.004"},{"key":"4672_CR170","doi-asserted-by":"publisher","unstructured":"Cantuti-Castelvetri L, Fitzner D, Bosch-Queralt M, Weil MT, Su M, Sen P et al (2018) Defective cholesterol clearance limits remyelination in the aged central nervous system. Science 684\u2013688. https:\/\/doi.org\/10.1126\/science.aan4183","DOI":"10.1126\/science.aan4183"},{"key":"4672_CR171","doi-asserted-by":"publisher","unstructured":"Camargo N, Goudriaan A, van Deijk A-LF, Otte WM, Brouwers JF, Lodder H et al (2017) Oligodendroglial myelination requires astrocyte-derived lipids. PLOS Biol e1002605. https:\/\/doi.org\/10.1371\/journal.pbio.1002605","DOI":"10.1371\/journal.pbio.1002605"},{"key":"4672_CR172","doi-asserted-by":"publisher","unstructured":"Zhang J, Xu X, Liu H, Jin L, Shen X, Xie C et al (2021) Astrocytic YAP prevents the demyelination through promoting expression of cholesterol synthesis genes in experimental autoimmune encephalomyelitis. Cell Death Dis https:\/\/doi.org\/10.1038\/s41419-021-04203-8","DOI":"10.1038\/s41419-021-04203-8"},{"key":"4672_CR173","doi-asserted-by":"publisher","unstructured":"Wang Z, Sadovnick AD, Traboulsee AL, Ross JP, Bernales CQ, Encarnacion M et al (2016) Nuclear receptor NR1H3 in familial multiple sclerosis. Neuron 948\u2013954. https:\/\/doi.org\/10.1016\/j.neuron.2016.04.039","DOI":"10.1016\/j.neuron.2016.04.039"},{"key":"4672_CR174","doi-asserted-by":"publisher","unstructured":"Wouters E, De Wit NM, Vanmol J, Van der Pol SMA, van Het Hof B, Sommer D et al (2019) Liver X receptor alpha is important in maintaining blood-brain barrier function. Front Immunol 1811. https:\/\/doi.org\/10.3389\/fimmu.2019.01811","DOI":"10.3389\/fimmu.2019.01811"},{"key":"4672_CR175","doi-asserted-by":"publisher","unstructured":"Meffre D, Shackleford G, Hichor M, Gorgievski V, Tzavara ET, Trousson A et al (2015) Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum. Proc Natl Acad Sci U S A 7587\u20137592. https:\/\/doi.org\/10.1073\/pnas.1424951112","DOI":"10.1073\/pnas.1424951112"},{"key":"4672_CR176","doi-asserted-by":"publisher","unstructured":"Ho WY, Chang JC, Lim K, Cazenave-Gassiot A, Nguyen AT, Foo JC et al (2021) Tdp-43 mediates srebf2-regulated gene expression required for oligodendrocyte myelination. J Cell Biol https:\/\/doi.org\/10.1083\/jcb.201910213","DOI":"10.1083\/jcb.201910213"},{"key":"4672_CR177","doi-asserted-by":"publisher","unstructured":"Liu X, Xin DE, Zhong X, Zhao C, Li Z, Zhang L et al (2024) Small-molecule-induced epigenetic rejuvenation promotes SREBP condensation and overcomes barriers to CNS myelin regeneration. Cell 2465\u20132484.e2422. https:\/\/doi.org\/10.1016\/j.cell.2024.04.005","DOI":"10.1016\/j.cell.2024.04.005"},{"key":"4672_CR178","doi-asserted-by":"publisher","unstructured":"Na Y, Ke L, Jie Z, Jinping W, Tao M, Jie Z et al (2023) Amelioration of cholesterol rich diet-induced impaired cognition in AD transgenic mice by an LXR agonist TO901317 is associated with the activation of the LXR-\u03b2-RXR-\u03b1-ABCA1 transmembrane transport system and improving the composition of lipid raft. Exp Aging Res 214\u2013225. https:\/\/doi.org\/10.1080\/0361073x.2022.2095605","DOI":"10.1080\/0361073x.2022.2095605"},{"key":"4672_CR179","doi-asserted-by":"publisher","unstructured":"Riddell DR, Zhou H, Comery TA, Kouranova E, Lo CF, Warwick HK et al (2007) The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer\u2019s disease. Mol Cell Neurosci 621\u2013628. https:\/\/doi.org\/10.1016\/j.mcn.2007.01.011","DOI":"10.1016\/j.mcn.2007.01.011"},{"key":"4672_CR180","doi-asserted-by":"publisher","unstructured":"Koldamova RP, Lefterov IM, Staufenbiel M, Wolfe D, Huang S, Glorioso JC et al (2005) The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer\u2019s disease. J Biol Chem 4079\u20134088. https:\/\/doi.org\/10.1074\/jbc.M411420200","DOI":"10.1074\/jbc.M411420200"},{"key":"4672_CR181","doi-asserted-by":"publisher","unstructured":"Fitz NF, Cronican A, Pham T, Fogg A, Fauq AH, Chapman R et al (2010) Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice. J Neurosci 6862\u20136872. https:\/\/doi.org\/10.1523\/jneurosci.1051-10.2010","DOI":"10.1523\/jneurosci.1051-10.2010"},{"key":"4672_CR182","doi-asserted-by":"publisher","unstructured":"Lefterov I, Bookout A, Wang Z, Staufenbiel M, Mangelsdorf D, Koldamova R (2007) Expression profiling in APP23 mouse brain: inhibition of A\u03b2 amyloidosis and inflammation in response to LXR agonist treatment. Mol Neurodegener 20. https:\/\/doi.org\/10.1186\/1750-1326-2-20","DOI":"10.1186\/1750-1326-2-20"},{"key":"4672_CR183","doi-asserted-by":"publisher","unstructured":"Courtney R, Landreth GE (2016) LXR regulation of brain cholesterol: from development to disease. Trends Endocrinol Metab 404\u2013414. https:\/\/doi.org\/10.1016\/j.tem.2016.03.018","DOI":"10.1016\/j.tem.2016.03.018"},{"key":"4672_CR184","doi-asserted-by":"publisher","unstructured":"Donkin JJ, Stukas S, Hirsch-Reinshagen V, Namjoshi D, Wilkinson A, May S et al (2010) ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein\/presenilin 1 mice. J Biol Chem 34144\u201334154. https:\/\/doi.org\/10.1074\/jbc.M110.108100","DOI":"10.1074\/jbc.M110.108100"},{"key":"4672_CR185","doi-asserted-by":"publisher","unstructured":"Abildayeva K, Jansen PJ, Hirsch-Reinshagen V, Bloks VW, Bakker AHF, Ramaekers FCS et al (2006) 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux*. J Biol Chem 12799\u201312808. https:\/\/doi.org\/10.1074\/jbc.M601019200","DOI":"10.1074\/jbc.M601019200"},{"key":"4672_CR186","doi-asserted-by":"publisher","unstructured":"Sodhi RK, Singh N (2013) Defensive effect of lansoprazole in dementia of AD type in mice exposed to streptozotocin and cholesterol enriched diet. PLoS One e70487. https:\/\/doi.org\/10.1371\/journal.pone.0070487","DOI":"10.1371\/journal.pone.0070487"},{"key":"4672_CR187","doi-asserted-by":"publisher","unstructured":"Cronican AA, Fitz NF, Pham T, Fogg A, Kifer B, Koldamova R et al (2010) Proton pump inhibitor Lansoprazole is a nuclear liver X receptor agonist. Biochem Pharmacol 1310\u20131316. https:\/\/doi.org\/10.1016\/j.bcp.2009.12.018","DOI":"10.1016\/j.bcp.2009.12.018"},{"key":"4672_CR188","doi-asserted-by":"publisher","unstructured":"Kratzer A, Buchebner M, Pfeifer T, Becker TM, Uray G, Miyazaki M et al (2009) Synthetic LXR agonist attenuates plaque formation in apoE-\/- mice without inducing liver steatosis and hypertriglyceridemia. J Lipid Res 312\u2013326. https:\/\/doi.org\/10.1194\/jlr.M800376-JLR200","DOI":"10.1194\/jlr.M800376-JLR200"},{"key":"4672_CR189","doi-asserted-by":"publisher","unstructured":"Navas Guimaraes ME, Lopez-Blanco R, Correa J, Fernandez-Villamarin M, Bistu\u00e9 MB, Martino-Adami P et al (2021) Liver X receptor activation with an intranasal polymer therapeutic prevents cognitive decline without altering lipid levels. ACS Nano 4678\u20134687. https:\/\/doi.org\/10.1021\/acsnano.0c09159","DOI":"10.1021\/acsnano.0c09159"},{"key":"4672_CR190","doi-asserted-by":"publisher","unstructured":"Birolini G, Verlengia G, Talpo F, Maniezzi C, Zentilin L, Giacca M et al (2021) SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington's disease phenotypes. Brain 3175\u20133190. https:\/\/doi.org\/10.1093\/brain\/awab186","DOI":"10.1093\/brain\/awab186"},{"key":"4672_CR191","doi-asserted-by":"publisher","unstructured":"Hindinger C, Hinton DR, Kirwin SJ, Atkinson RD, Burnett ME, Bergmann CC et al (2006) Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis. J Neurosci Res 1225\u20131234. https:\/\/doi.org\/10.1002\/jnr.21038","DOI":"10.1002\/jnr.21038"},{"key":"4672_CR192","doi-asserted-by":"publisher","unstructured":"Nugent AA, Lin K, van Lengerich B, Lianoglou S, Przybyla L, Davis SS et al (2020) TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge. Neuron 837\u2013854.e839. https:\/\/doi.org\/10.1016\/j.neuron.2019.12.007","DOI":"10.1016\/j.neuron.2019.12.007"},{"key":"4672_CR193","doi-asserted-by":"publisher","unstructured":"Zhang R, Dong Y, Liu Y, Moezzi D, Ghorbani S, Mirzaei R et al (2023) Enhanced liver X receptor signalling reduces brain injury and promotes tissue regeneration following experimental intracerebral haemorrhage: roles of microglia\/macrophages. Stroke Vasc Neurol 486\u2013502. https:\/\/doi.org\/10.1136\/svn-2023-002331","DOI":"10.1136\/svn-2023-002331"},{"key":"4672_CR194","doi-asserted-by":"publisher","unstructured":"Cui G, Qin X, Wu L, Zhang Y, Sheng X, Yu Q et al (2011) Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J Clin Invest 658\u2013670. https:\/\/doi.org\/10.1172\/jci42974","DOI":"10.1172\/jci42974"},{"key":"4672_CR195","doi-asserted-by":"publisher","unstructured":"Xu P, Li D, Tang X, Bao X, Huang J, Tang Y et al (2013) LXR agonists: new potential therapeutic drug for neurodegenerative diseases. Mol Neurobiol 715\u2013728. https:\/\/doi.org\/10.1007\/s12035-013-8461-3","DOI":"10.1007\/s12035-013-8461-3"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04672-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04672-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04672-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:07:06Z","timestamp":1743379626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04672-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":195,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["4672"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04672-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}